Human ESC‐sEVs alleviate age‐related bone loss by rejuvenating senescent bone marrow‐derived mesenchymal stem cells. Issue 1 (10th August 2020)

• Record Type: Journal Article
• Authors: Gong, Liangzhi; Chen, Bi; Zhang, Juntao; Sun, Yongjin; Yuan, Ji; Niu, Xin; Hu, Guowen; Chen, Yu; Xie, Zongping; Deng, Zhifeng; Li, Qing; Wang, Yang
• Is Part Of: Journal of extracellular vesicles. Volume 9:Issue 1(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-08-10
• Subjects: Extracellular vesicle -- embryonic stem cells -- cellular senescence -- bone loss -- bone marrow MSCs; Cells -- Mechanical properties -- Periodicals; Transport Vesicles; Cells -- Mechanical properties; Periodicals; Fulltext; Internet Resources; Periodicals; Electronic journals; Periodicals; 571.63
• DOI: 10.1080/20013078.2020.1800971
• Languages: English
• ISSNs: 2001-3078

Abstract

ABSTRACT: Tissue‐resident stem cell senescence leads to stem cell exhaustion, which is a major cause of physiological and pathological ageing. Stem cell‐derived extracellular vesicles (SC‐EVs) have been reported in preclinical studies to possess therapeutic potential for diverse diseases. However, whether SC‐EVs can rejuvenate senescent tissue stem cells to prevent age‐related disorders still remains unknown. Here, we show that chronic application of human embryonic stem cell‐derived small extracellular vesicles (hESC‐sEVs) rescues the function of senescent bone marrow mesenchymal stem cells (BM‐MSCs) and prevents age‐related bone loss in ageing mice. Transcriptome analysis revealed that hESC‐sEVs treatment upregulated the expression of genes involved in antiaging, stem cell proliferation and osteogenic differentiation in BM‐MSCs. Furthermore, liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) analysis identified 4122 proteins encapsulated in hESC‐sEVs. Bioinformatics analysis predicted that the protein components in the hESCs‐sEVs function in a synergistic way to induce the activation of several canonical signalling pathways, including Wnt, Sirtuin, AMPK, PTEN signalling, which results in the upregulation of antiaging genes in BM‐MSCs and then the recovery of senescent BM‐MSCs function. Collectively, our findings reveal the effect of hESC‐sEVs in reversing BM‐MSCs senescence and age‐related osteogenic dysfunction, thereby preventing age‐related bone loss. Because hESC‐sEVs could alleviate senescence of tissue‐resident stem cells, they might be promising therapeutic candidates for age‐related diseases.